Global β-Lactam Antibiotics Market Growth 2022-2028
β-lactam antibiotics refer to a large class of antibiotics with a β-lactam ring in their chemical structure. These antibiotics have the advantages of strong bactericidal activity, low toxicity, wide indications and good clinical efficacy.
The global market for β-Lactam Antibiotics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC β-Lactam Antibiotics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States β-Lactam Antibiotics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe β-Lactam Antibiotics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China β-Lactam Antibiotics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key β-Lactam Antibiotics players cover ACS Dobfar, CSPC, United Laboratories, Novartis and LKPC, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global β-Lactam Antibiotics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global β-Lactam Antibiotics market, with both quantitative and qualitative data, to help readers understand how the β-Lactam Antibiotics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the β-Lactam Antibiotics market and forecasts the market size by Type (Penicillin, Oxycephems and Carbapenems), by Application (Hospital and Clinic.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Penicillin
Oxycephems
Carbapenems
Cephalosporins
Others
Segmentation by application
Hospital
Clinic
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
ACS Dobfar
CSPC
United Laboratories
Novartis
LKPC
Changsheng Pharma
North China Pharmaceuticals
Centrient Pharmaceutical
Aurobindo Pharma
Yili Chuanning Biotechnology
Jiangxi Fushine Pharmaceutical
QILU Pharmaceutical
Jiangxi Huabang Pharmaceutical
Chapter Introduction
Chapter 1: Scope of β-Lactam Antibiotics, Research Methodology, etc.
Chapter 2: Executive Summary, global β-Lactam Antibiotics market size (sales and revenue) and CAGR, β-Lactam Antibiotics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: β-Lactam Antibiotics sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global β-Lactam Antibiotics sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global β-Lactam Antibiotics market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including ACS Dobfar, CSPC, United Laboratories, Novartis, LKPC, Changsheng Pharma, North China Pharmaceuticals, Centrient Pharmaceutical and Aurobindo Pharma, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global β-Lactam Antibiotics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for β-Lactam Antibiotics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for β-Lactam Antibiotics by Country/Region, 2017, 2022 & 2028
2.2 β-Lactam Antibiotics Segment by Type
2.2.1 Penicillin
2.2.2 Oxycephems
2.2.3 Carbapenems
2.2.4 Cephalosporins
2.2.5 Others
2.3 β-Lactam Antibiotics Sales by Type
2.3.1 Global β-Lactam Antibiotics Sales Market Share by Type (2017-2022)
2.3.2 Global β-Lactam Antibiotics Revenue and Market Share by Type (2017-2022)
2.3.3 Global β-Lactam Antibiotics Sale Price by Type (2017-2022)
2.4 β-Lactam Antibiotics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 β-Lactam Antibiotics Sales by Application
2.5.1 Global β-Lactam Antibiotics Sale Market Share by Application (2017-2022)
2.5.2 Global β-Lactam Antibiotics Revenue and Market Share by Application (2017-2022)
2.5.3 Global β-Lactam Antibiotics Sale Price by Application (2017-2022)
3 Global β-Lactam Antibiotics by Company
3.1 Global β-Lactam Antibiotics Breakdown Data by Company
3.1.1 Global β-Lactam Antibiotics Annual Sales by Company (2020-2022)
3.1.2 Global β-Lactam Antibiotics Sales Market Share by Company (2020-2022)
3.2 Global β-Lactam Antibiotics Annual Revenue by Company (2020-2022)
3.2.1 Global β-Lactam Antibiotics Revenue by Company (2020-2022)
3.2.2 Global β-Lactam Antibiotics Revenue Market Share by Company (2020-2022)
3.3 Global β-Lactam Antibiotics Sale Price by Company
3.4 Key Manufacturers β-Lactam Antibiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers β-Lactam Antibiotics Product Location Distribution
3.4.2 Players β-Lactam Antibiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for β-Lactam Antibiotics by Geographic Region
4.1 World Historic β-Lactam Antibiotics Market Size by Geographic Region (2017-2022)
4.1.1 Global β-Lactam Antibiotics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global β-Lactam Antibiotics Annual Revenue by Geographic Region
4.2 World Historic β-Lactam Antibiotics Market Size by Country/Region (2017-2022)
4.2.1 Global β-Lactam Antibiotics Annual Sales by Country/Region (2017-2022)
4.2.2 Global β-Lactam Antibiotics Annual Revenue by Country/Region
4.3 Americas β-Lactam Antibiotics Sales Growth
4.4 APAC β-Lactam Antibiotics Sales Growth
4.5 Europe β-Lactam Antibiotics Sales Growth
4.6 Middle East & Africa β-Lactam Antibiotics Sales Growth
5 Americas
5.1 Americas β-Lactam Antibiotics Sales by Country
5.1.1 Americas β-Lactam Antibiotics Sales by Country (2017-2022)
5.1.2 Americas β-Lactam Antibiotics Revenue by Country (2017-2022)
5.2 Americas β-Lactam Antibiotics Sales by Type
5.3 Americas β-Lactam Antibiotics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC β-Lactam Antibiotics Sales by Region
6.1.1 APAC β-Lactam Antibiotics Sales by Region (2017-2022)
6.1.2 APAC β-Lactam Antibiotics Revenue by Region (2017-2022)
6.2 APAC β-Lactam Antibiotics Sales by Type
6.3 APAC β-Lactam Antibiotics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe β-Lactam Antibiotics by Country
7.1.1 Europe β-Lactam Antibiotics Sales by Country (2017-2022)
7.1.2 Europe β-Lactam Antibiotics Revenue by Country (2017-2022)
7.2 Europe β-Lactam Antibiotics Sales by Type
7.3 Europe β-Lactam Antibiotics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa β-Lactam Antibiotics by Country
8.1.1 Middle East & Africa β-Lactam Antibiotics Sales by Country (2017-2022)
8.1.2 Middle East & Africa β-Lactam Antibiotics Revenue by Country (2017-2022)
8.2 Middle East & Africa β-Lactam Antibiotics Sales by Type
8.3 Middle East & Africa β-Lactam Antibiotics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of β-Lactam Antibiotics
10.3 Manufacturing Process Analysis of β-Lactam Antibiotics
10.4 Industry Chain Structure of β-Lactam Antibiotics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 β-Lactam Antibiotics Distributors
11.3 β-Lactam Antibiotics Customer
12 World Forecast Review for β-Lactam Antibiotics by Geographic Region
12.1 Global β-Lactam Antibiotics Market Size Forecast by Region
12.1.1 Global β-Lactam Antibiotics Forecast by Region (2023-2028)
12.1.2 Global β-Lactam Antibiotics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global β-Lactam Antibiotics Forecast by Type
12.7 Global β-Lactam Antibiotics Forecast by Application
13 Key Players Analysis
13.1 ACS Dobfar
13.1.1 ACS Dobfar Company Information
13.1.2 ACS Dobfar β-Lactam Antibiotics Product Offered
13.1.3 ACS Dobfar β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ACS Dobfar Main Business Overview
13.1.5 ACS Dobfar Latest Developments
13.2 CSPC
13.2.1 CSPC Company Information
13.2.2 CSPC β-Lactam Antibiotics Product Offered
13.2.3 CSPC β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSPC Main Business Overview
13.2.5 CSPC Latest Developments
13.3 United Laboratories
13.3.1 United Laboratories Company Information
13.3.2 United Laboratories β-Lactam Antibiotics Product Offered
13.3.3 United Laboratories β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 United Laboratories Main Business Overview
13.3.5 United Laboratories Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis β-Lactam Antibiotics Product Offered
13.4.3 Novartis β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 LKPC
13.5.1 LKPC Company Information
13.5.2 LKPC β-Lactam Antibiotics Product Offered
13.5.3 LKPC β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 LKPC Main Business Overview
13.5.5 LKPC Latest Developments
13.6 Changsheng Pharma
13.6.1 Changsheng Pharma Company Information
13.6.2 Changsheng Pharma β-Lactam Antibiotics Product Offered
13.6.3 Changsheng Pharma β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Changsheng Pharma Main Business Overview
13.6.5 Changsheng Pharma Latest Developments
13.7 North China Pharmaceuticals
13.7.1 North China Pharmaceuticals Company Information
13.7.2 North China Pharmaceuticals β-Lactam Antibiotics Product Offered
13.7.3 North China Pharmaceuticals β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 North China Pharmaceuticals Main Business Overview
13.7.5 North China Pharmaceuticals Latest Developments
13.8 Centrient Pharmaceutical
13.8.1 Centrient Pharmaceutical Company Information
13.8.2 Centrient Pharmaceutical β-Lactam Antibiotics Product Offered
13.8.3 Centrient Pharmaceutical β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Centrient Pharmaceutical Main Business Overview
13.8.5 Centrient Pharmaceutical Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma β-Lactam Antibiotics Product Offered
13.9.3 Aurobindo Pharma β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 Yili Chuanning Biotechnology
13.10.1 Yili Chuanning Biotechnology Company Information
13.10.2 Yili Chuanning Biotechnology β-Lactam Antibiotics Product Offered
13.10.3 Yili Chuanning Biotechnology β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Yili Chuanning Biotechnology Main Business Overview
13.10.5 Yili Chuanning Biotechnology Latest Developments
13.11 Jiangxi Fushine Pharmaceutical
13.11.1 Jiangxi Fushine Pharmaceutical Company Information
13.11.2 Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Product Offered
13.11.3 Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Jiangxi Fushine Pharmaceutical Main Business Overview
13.11.5 Jiangxi Fushine Pharmaceutical Latest Developments
13.12 QILU Pharmaceutical
13.12.1 QILU Pharmaceutical Company Information
13.12.2 QILU Pharmaceutical β-Lactam Antibiotics Product Offered
13.12.3 QILU Pharmaceutical β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 QILU Pharmaceutical Main Business Overview
13.12.5 QILU Pharmaceutical Latest Developments
13.13 Jiangxi Huabang Pharmaceutical
13.13.1 Jiangxi Huabang Pharmaceutical Company Information
13.13.2 Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Product Offered
13.13.3 Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Jiangxi Huabang Pharmaceutical Main Business Overview
13.13.5 Jiangxi Huabang Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. β-Lactam Antibiotics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. β-Lactam Antibiotics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Penicillin
Table 4. Major Players of Oxycephems
Table 5. Major Players of Carbapenems
Table 6. Major Players of Cephalosporins
Table 7. Major Players of Others
Table 8. Global β-Lactam Antibiotics Sales by Type (2017-2022) & (K Units)
Table 9. Global β-Lactam Antibiotics Sales Market Share by Type (2017-2022)
Table 10. Global β-Lactam Antibiotics Revenue by Type (2017-2022) & ($ million)
Table 11. Global β-Lactam Antibiotics Revenue Market Share by Type (2017-2022)
Table 12. Global β-Lactam Antibiotics Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global β-Lactam Antibiotics Sales by Application (2017-2022) & (K Units)
Table 14. Global β-Lactam Antibiotics Sales Market Share by Application (2017-2022)
Table 15. Global β-Lactam Antibiotics Revenue by Application (2017-2022)
Table 16. Global β-Lactam Antibiotics Revenue Market Share by Application (2017-2022)
Table 17. Global β-Lactam Antibiotics Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global β-Lactam Antibiotics Sales by Company (2020-2022) & (K Units)
Table 19. Global β-Lactam Antibiotics Sales Market Share by Company (2020-2022)
Table 20. Global β-Lactam Antibiotics Revenue by Company (2020-2022) ($ Millions)
Table 21. Global β-Lactam Antibiotics Revenue Market Share by Company (2020-2022)
Table 22. Global β-Lactam Antibiotics Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers β-Lactam Antibiotics Producing Area Distribution and Sales Area
Table 24. Players β-Lactam Antibiotics Products Offered
Table 25. β-Lactam Antibiotics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global β-Lactam Antibiotics Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global β-Lactam Antibiotics Sales Market Share Geographic Region (2017-2022)
Table 30. Global β-Lactam Antibiotics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global β-Lactam Antibiotics Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global β-Lactam Antibiotics Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global β-Lactam Antibiotics Sales Market Share by Country/Region (2017-2022)
Table 34. Global β-Lactam Antibiotics Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global β-Lactam Antibiotics Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas β-Lactam Antibiotics Sales by Country (2017-2022) & (K Units)
Table 37. Americas β-Lactam Antibiotics Sales Market Share by Country (2017-2022)
Table 38. Americas β-Lactam Antibiotics Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas β-Lactam Antibiotics Revenue Market Share by Country (2017-2022)
Table 40. Americas β-Lactam Antibiotics Sales by Type (2017-2022) & (K Units)
Table 41. Americas β-Lactam Antibiotics Sales Market Share by Type (2017-2022)
Table 42. Americas β-Lactam Antibiotics Sales by Application (2017-2022) & (K Units)
Table 43. Americas β-Lactam Antibiotics Sales Market Share by Application (2017-2022)
Table 44. APAC β-Lactam Antibiotics Sales by Region (2017-2022) & (K Units)
Table 45. APAC β-Lactam Antibiotics Sales Market Share by Region (2017-2022)
Table 46. APAC β-Lactam Antibiotics Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC β-Lactam Antibiotics Revenue Market Share by Region (2017-2022)
Table 48. APAC β-Lactam Antibiotics Sales by Type (2017-2022) & (K Units)
Table 49. APAC β-Lactam Antibiotics Sales Market Share by Type (2017-2022)
Table 50. APAC β-Lactam Antibiotics Sales by Application (2017-2022) & (K Units)
Table 51. APAC β-Lactam Antibiotics Sales Market Share by Application (2017-2022)
Table 52. Europe β-Lactam Antibiotics Sales by Country (2017-2022) & (K Units)
Table 53. Europe β-Lactam Antibiotics Sales Market Share by Country (2017-2022)
Table 54. Europe β-Lactam Antibiotics Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe β-Lactam Antibiotics Revenue Market Share by Country (2017-2022)
Table 56. Europe β-Lactam Antibiotics Sales by Type (2017-2022) & (K Units)
Table 57. Europe β-Lactam Antibiotics Sales Market Share by Type (2017-2022)
Table 58. Europe β-Lactam Antibiotics Sales by Application (2017-2022) & (K Units)
Table 59. Europe β-Lactam Antibiotics Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa β-Lactam Antibiotics Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa β-Lactam Antibiotics Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa β-Lactam Antibiotics Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa β-Lactam Antibiotics Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa β-Lactam Antibiotics Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa β-Lactam Antibiotics Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa β-Lactam Antibiotics Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa β-Lactam Antibiotics Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of β-Lactam Antibiotics
Table 69. Key Market Challenges & Risks of β-Lactam Antibiotics
Table 70. Key Industry Trends of β-Lactam Antibiotics
Table 71. β-Lactam Antibiotics Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. β-Lactam Antibiotics Distributors List
Table 74. β-Lactam Antibiotics Customer List
Table 75. Global β-Lactam Antibiotics Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global β-Lactam Antibiotics Sales Market Forecast by Region
Table 77. Global β-Lactam Antibiotics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global β-Lactam Antibiotics Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas β-Lactam Antibiotics Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas β-Lactam Antibiotics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC β-Lactam Antibiotics Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC β-Lactam Antibiotics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe β-Lactam Antibiotics Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe β-Lactam Antibiotics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa β-Lactam Antibiotics Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa β-Lactam Antibiotics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global β-Lactam Antibiotics Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global β-Lactam Antibiotics Sales Market Share Forecast by Type (2023-2028)
Table 89. Global β-Lactam Antibiotics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global β-Lactam Antibiotics Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global β-Lactam Antibiotics Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global β-Lactam Antibiotics Sales Market Share Forecast by Application (2023-2028)
Table 93. Global β-Lactam Antibiotics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global β-Lactam Antibiotics Revenue Market Share Forecast by Application (2023-2028)
Table 95. ACS Dobfar Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 96. ACS Dobfar β-Lactam Antibiotics Product Offered
Table 97. ACS Dobfar β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. ACS Dobfar Main Business
Table 99. ACS Dobfar Latest Developments
Table 100. CSPC Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 101. CSPC β-Lactam Antibiotics Product Offered
Table 102. CSPC β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. CSPC Main Business
Table 104. CSPC Latest Developments
Table 105. United Laboratories Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 106. United Laboratories β-Lactam Antibiotics Product Offered
Table 107. United Laboratories β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. United Laboratories Main Business
Table 109. United Laboratories Latest Developments
Table 110. Novartis Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 111. Novartis β-Lactam Antibiotics Product Offered
Table 112. Novartis β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. Novartis Main Business
Table 114. Novartis Latest Developments
Table 115. LKPC Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 116. LKPC β-Lactam Antibiotics Product Offered
Table 117. LKPC β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. LKPC Main Business
Table 119. LKPC Latest Developments
Table 120. Changsheng Pharma Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 121. Changsheng Pharma β-Lactam Antibiotics Product Offered
Table 122. Changsheng Pharma β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Changsheng Pharma Main Business
Table 124. Changsheng Pharma Latest Developments
Table 125. North China Pharmaceuticals Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 126. North China Pharmaceuticals β-Lactam Antibiotics Product Offered
Table 127. North China Pharmaceuticals β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. North China Pharmaceuticals Main Business
Table 129. North China Pharmaceuticals Latest Developments
Table 130. Centrient Pharmaceutical Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 131. Centrient Pharmaceutical β-Lactam Antibiotics Product Offered
Table 132. Centrient Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Centrient Pharmaceutical Main Business
Table 134. Centrient Pharmaceutical Latest Developments
Table 135. Aurobindo Pharma Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 136. Aurobindo Pharma β-Lactam Antibiotics Product Offered
Table 137. Aurobindo Pharma β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Aurobindo Pharma Main Business
Table 139. Aurobindo Pharma Latest Developments
Table 140. Yili Chuanning Biotechnology Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 141. Yili Chuanning Biotechnology β-Lactam Antibiotics Product Offered
Table 142. Yili Chuanning Biotechnology β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Yili Chuanning Biotechnology Main Business
Table 144. Yili Chuanning Biotechnology Latest Developments
Table 145. Jiangxi Fushine Pharmaceutical Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 146. Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Product Offered
Table 147. Jiangxi Fushine Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Jiangxi Fushine Pharmaceutical Main Business
Table 149. Jiangxi Fushine Pharmaceutical Latest Developments
Table 150. QILU Pharmaceutical Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 151. QILU Pharmaceutical β-Lactam Antibiotics Product Offered
Table 152. QILU Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. QILU Pharmaceutical Main Business
Table 154. QILU Pharmaceutical Latest Developments
Table 155. Jiangxi Huabang Pharmaceutical Basic Information, β-Lactam Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 156. Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Product Offered
Table 157. Jiangxi Huabang Pharmaceutical β-Lactam Antibiotics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. Jiangxi Huabang Pharmaceutical Main Business
Table 159. Jiangxi Huabang Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of β-Lactam Antibiotics
Figure 2. β-Lactam Antibiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global β-Lactam Antibiotics Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global β-Lactam Antibiotics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. β-Lactam Antibiotics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Penicillin
Figure 10. Product Picture of Oxycephems
Figure 11. Product Picture of Carbapenems
Figure 12. Product Picture of Cephalosporins
Figure 13. Product Picture of Others
Figure 14. Global β-Lactam Antibiotics Sales Market Share by Type in 2021
Figure 15. Global β-Lactam Antibiotics Revenue Market Share by Type (2017-2022)
Figure 16. β-Lactam Antibiotics Consumed in Hospital
Figure 17. Global β-Lactam Antibiotics Market: Hospital (2017-2022) & (K Units)
Figure 18. β-Lactam Antibiotics Consumed in Clinic
Figure 19. Global β-Lactam Antibiotics Market: Clinic (2017-2022) & (K Units)
Figure 20. Global β-Lactam Antibiotics Sales Market Share by Application (2017-2022)
Figure 21. Global β-Lactam Antibiotics Revenue Market Share by Application in 2021
Figure 22. β-Lactam Antibiotics Revenue Market by Company in 2021 ($ Million)
Figure 23. Global β-Lactam Antibiotics Revenue Market Share by Company in 2021
Figure 24. Global β-Lactam Antibiotics Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global β-Lactam Antibiotics Revenue Market Share by Geographic Region in 2021
Figure 26. Global β-Lactam Antibiotics Sales Market Share by Region (2017-2022)
Figure 27. Global β-Lactam Antibiotics Revenue Market Share by Country/Region in 2021
Figure 28. Americas β-Lactam Antibiotics Sales 2017-2022 (K Units)
Figure 29. Americas β-Lactam Antibiotics Revenue 2017-2022 ($ Millions)
Figure 30. APAC β-Lactam Antibiotics Sales 2017-2022 (K Units)
Figure 31. APAC β-Lactam Antibiotics Revenue 2017-2022 ($ Millions)
Figure 32. Europe β-Lactam Antibiotics Sales 2017-2022 (K Units)
Figure 33. Europe β-Lactam Antibiotics Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa β-Lactam Antibiotics Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa β-Lactam Antibiotics Revenue 2017-2022 ($ Millions)
Figure 36. Americas β-Lactam Antibiotics Sales Market Share by Country in 2021
Figure 37. Americas β-Lactam Antibiotics Revenue Market Share by Country in 2021
Figure 38. United States β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC β-Lactam Antibiotics Sales Market Share by Region in 2021
Figure 43. APAC β-Lactam Antibiotics Revenue Market Share by Regions in 2021
Figure 44. China β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 48. India β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe β-Lactam Antibiotics Sales Market Share by Country in 2021
Figure 51. Europe β-Lactam Antibiotics Revenue Market Share by Country in 2021
Figure 52. Germany β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 53. France β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa β-Lactam Antibiotics Sales Market Share by Country in 2021
Figure 58. Middle East & Africa β-Lactam Antibiotics Revenue Market Share by Country in 2021
Figure 59. Egypt β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country β-Lactam Antibiotics Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of β-Lactam Antibiotics in 2021
Figure 65. Manufacturing Process Analysis of β-Lactam Antibiotics
Figure 66. Industry Chain Structure of β-Lactam Antibiotics
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets